185 related articles for article (PubMed ID: 17025252)
21. Anti-inflammatory and pharmacokinetics evaluation of PEGylated ibuprofen tablet formulation.
Mumuni M; Kenechukwu FC; Chime SA; Ogbonna JD; Mora AT
Drug Deliv; 2014 Jun; 21(4):315-9. PubMed ID: 24191762
[TBL] [Abstract][Full Text] [Related]
22. Formulation and in vitro and in vivo availability of diclofenac sodium enteric-coated beads.
Hosny EA; el-Mahrouk GM; Gouda MW
Drug Dev Ind Pharm; 1998 Jul; 24(7):661-6. PubMed ID: 9876511
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics of ibuprofen following a single administration of a suspension containing enteric-coated microcapsules.
Walter K; Weiss G; Laicher A; Stanislaus F
Arzneimittelforschung; 1995 Aug; 45(8):886-90. PubMed ID: 7575754
[TBL] [Abstract][Full Text] [Related]
24. Xanthan gum to tailor drug release of sustained-release ethylcellulose mini-matrices prepared via hot-melt extrusion: in vitro and in vivo evaluation.
Verhoeven E; Vervaet C; Remon JP
Eur J Pharm Biopharm; 2006 Jul; 63(3):320-30. PubMed ID: 16517135
[TBL] [Abstract][Full Text] [Related]
25. Lappaconitine-loaded microspheres for parenteral sustained release: effects of formulation variables and in vitro characterization.
Xu H; Zhong H; Liu M; Xu C; Gao Y
Pharmazie; 2011 Sep; 66(9):654-61. PubMed ID: 22026119
[TBL] [Abstract][Full Text] [Related]
26. Preparation and evaluation of ibuprofen-loaded microemulsion for improvement of oral bioavailability.
Hu L; Yang J; Liu W; Li L
Drug Deliv; 2011 Jan; 18(1):90-5. PubMed ID: 20942639
[TBL] [Abstract][Full Text] [Related]
27. [The pharmacokinetics and bioequivalence of acipimox sustained-release tablets after a single and multiple oral administration in healthy dogs].
Yang XG; Nie SF; Bai HJ; Zhang GJ; Pan WS
Yao Xue Xue Bao; 2005 May; 40(5):457-61. PubMed ID: 16220793
[TBL] [Abstract][Full Text] [Related]
28. Citric acid as a pH-regulating additive in granules and the tablet matrix in enteric-coated formulations for colon-specific drug delivery.
Nykänen P; Sten T; Jürjenson H; Veski P; Marvola M
Pharmazie; 2004 Apr; 59(4):268-73. PubMed ID: 15125570
[TBL] [Abstract][Full Text] [Related]
29. Improving the tablet characteristics and dissolution profile of ibuprofen by using a novel coprocessed superdisintegrant: a technical note.
Gohel M; Parikh R; Brahmbhatt B; Shah A
AAPS PharmSciTech; 2007 Feb; 8(1):13. PubMed ID: 17408213
[TBL] [Abstract][Full Text] [Related]
30. Fabrication of drug-loaded biodegradable microcapsules for controlled release by combination of solvent evaporation and layer-by-layer self-assembly.
Wang C; Ye W; Zheng Y; Liu X; Tong Z
Int J Pharm; 2007 Jun; 338(1-2):165-73. PubMed ID: 17324539
[TBL] [Abstract][Full Text] [Related]
31. Morning versus evening dosing of ibuprofen using conventional and time-controlled release formulations.
Halsas M; Hietala J; Veski P; Jürjenson H; Marvola M
Int J Pharm; 1999 Nov; 189(2):179-85. PubMed ID: 10536246
[TBL] [Abstract][Full Text] [Related]
32. In vitro - in vivo evaluation of a new oral dosage form of tramadol hydrochloride--controlled-release capsules filled with coated pellets.
Szkutnik-Fiedler D; Balcerkiewicz M; Sawicki W; Grabowski T; Grześkowiak E; Mazgalski J; Urjasz H
Acta Pol Pharm; 2014; 71(3):469-75. PubMed ID: 25265827
[TBL] [Abstract][Full Text] [Related]
33. In-vitro evaluation of sustained release ibuprofen microspheres.
Ghaly ES; Sepúlveda S
P R Health Sci J; 1996 Jun; 15(2):97-100. PubMed ID: 8936613
[TBL] [Abstract][Full Text] [Related]
34. Study of the preparation of sustained-release microspheres containing zedoary turmeric oil by the emulsion-solvent-diffusion method and evaluation of the self-emulsification and bioavailability of the oil.
You J; Cui FD; Han X; Wang YS; Yang L; Yu YW; Li QP
Colloids Surf B Biointerfaces; 2006 Mar; 48(1):35-41. PubMed ID: 16480856
[TBL] [Abstract][Full Text] [Related]
35. Rationale for ibuprofen co-administration with antacids: potential interaction mechanisms affecting drug absorption.
Parojcić J; Corrigan OI
Eur J Pharm Biopharm; 2008 Jun; 69(2):640-7. PubMed ID: 18280125
[TBL] [Abstract][Full Text] [Related]
36. A study to compare ibuprofen effervescent granules with ibuprofen tablets in the treatment of acute dental pain.
Sharma NK; Kindelan JD; Hutchinson D; Lancaster L
Prim Dent Care; 1994 Sep; 1(1):5-8. PubMed ID: 8941780
[TBL] [Abstract][Full Text] [Related]
37. Chemical, dissolution stability and microscopic evaluation of suspensions of ibuprofen and sustained release ibuprofen-wax microspheres.
Adeyeye CM; Price JC
J Microencapsul; 1997; 14(3):357-77. PubMed ID: 9147285
[TBL] [Abstract][Full Text] [Related]
38. New solid lipid microparticles for controlled ibuprofen release: formulation and characterization study.
Perge L; Robitzer M; Guillemot C; Devoisselle JM; Quignard F; Legrand P
Int J Pharm; 2012 Jan; 422(1-2):59-67. PubMed ID: 22027394
[TBL] [Abstract][Full Text] [Related]
39. Two release rates from monolithic carboxymethyl starch tablets: formulation, characterization, and in vitro/in vivo evaluation.
Le TC; Mateescu MA
Drug Deliv Transl Res; 2017 Aug; 7(4):516-528. PubMed ID: 28386870
[TBL] [Abstract][Full Text] [Related]
40. Investigation of surfactant/cosurfactant synergism impact on ibuprofen solubilization capacity and drug release characteristics of nonionic microemulsions.
Djekic L; Primorac M; Filipic S; Agbaba D
Int J Pharm; 2012 Aug; 433(1-2):25-33. PubMed ID: 22579578
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
